Increased late mortality with percutaneous stenting for unprotected left main coronary artery stenosis relative to coronary artery bypass grafting: A meta-analysis of observational studies  by Takagi, Hisato et al.
BRIEF RESEARCH REPORTIncreased late mortality with percutaneous stenting for unprotected
left main coronary artery stenosis relative to coronary artery bypass
grafting: A meta-analysis of observational studiesHisato Takagi, MD, PhD, Masafumi Matsui, MD, and Takuya Umemoto, MD, PhD, Shizuoka, JapanA recent meta-analysis by Naik and associates1 of 3733 pa-
tients in 2 randomized trials and 8 observational studies
revealed no difference in mortality for as long as 3 years
between percutaneous coronary stenting (PCS) and coronary
artery bypass grafting (CABG) for the treatment of unpro-
tected left main coronary artery (ULMCA) stenosis. Naik
and associates1 extracted and combined not adjusted but
unadjusted odds ratios (ORs) for mortality at each of years
1, 2, and 3 after treatment. It is usually appropriate for non-
randomized studies to analyze adjusted rather than unad-
justed effect estimates, however, and the most appropriate
way of summarizing time-to-event data is to use methods
of survival analysis and express the intervention effect as
a hazard ratio (HR).2 We performed a meta-analysis of com-TABLE 1. Studies included in the meta-analysis
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The Journal of Thoracic and Carparative studies of PCS versus CABG for prevention of late
mortality (1 year) in ULMCA stenosis that combined
adjusted HRs.METHODS
All comparative studies of PCS versus CABG enrolling patients with
ULMCA stenosis were selected with a 2-level search strategy. First, public
domain databases including MEDLINE, EMBASE, and the Cochrane
Central Register of Controlled Trials (current through December 2009)
were searched with internet-based search engines (PubMed, OVID). Sec-
ond, relevant studies were culled through a manual search of secondary
sources, including references of initially identified articles and a search of
reviews and commentaries. Studies considered for inclusion met the follow-
ing criteria (Tables 1 and 2): the design was a comparative study; the study
population consisted of patients with ULMCA stenosis; patients were
assigned to PCS versus CABG; and main outcomes included adjusted HR
for mortality with at least 1-year follow-up. Study-specific estimates were
combined with inverse variance-weighted averages of logarithmic HRs in
both fixed- and random-effects models. Where no significant statistical het-
erogeneity was found, the fixed-effects estimate was used preferentially as
the summary measure. Publication bias was assessed mathematically with
an adjusted rank correlation test. Metaregression analyses of summary
statistics were conducted to investigate the effects of percentages of patients
receiving drug-eluting stents and those undergoing off-pumpCABG on log-
arithmic HRs for mortality in an unrestricted maximum likelihood model.
All analyses were conducted with Review Manager version 5.0 (Nordic
Cochrane Centre, Copenhagen, Denmark) and Comprehensive Meta-
Analysis version 2 (Biostat, Englewood, NJ).PCS CABG
ethod Follow-up (y) N DES N OPCAB
ory of myocardial
diabetes mellitus,
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egression adjusted
acute coronary
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g-eluting stents; OPCAB, off-pump coronary artery bypass; EF, ejection fraction;
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TABLE 2. Studies excluded from the meta-analysis
First author Reference Reasons for exclusion
Buszman J Am Coll Cardiol. 2008;51:538-45 No HR could be abstracted
Chieffo Circulation. 2006;113:2542-7 No adjusted HR (only adjusted odds ratio) could be abstracted
Hsu Int Heart J. 2008;49:355-70 No adjusted risk estimates could be abstracted
Lee J Am Coll Cardiol. 2006;47:864-70 No adjusted risk estimates could be abstracted
Rode´s-Cabau Circulation. 2008;118:2374-81 No adjusted risk estimates could be abstracted
Sanmartı´n Am J Cardiol. 2007;100:970-3 No adjusted risk estimates could be abstracted
Serruys (SYNTAX) N Engl J Med. 2009;360:961-72 No HR could be abstracted; only 39% of patients had
unprotected left main coronary artery stenosis
HR, Hazard ratio; SYNTAX, Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery.
Brief Research ReportRESULTS
Our search selected 7 qualifying nonrandomized studies
of PCS versus CABG that enrolled patients with ULMCA
stenosis (Table 1). In total, our meta-analysis included data
on 2841 patients with ULMCA stenosis assigned to undergo
PCS or CABG.
Pooled analysis of the 7 studies demonstrated a statisti-
cally significant 35% increase in HR for mortality with
PCS relative to CABG (fixed-effects HR, 1.35; 95% confi-
dence interval [CI], 1.04–1.75; effect P¼ .02; heterogeneity
P ¼ .11; Figure 1, A). There was no evidence of significantFIGURE 1. A, Late mortality among patients assigned to percutaneous coro
Standard error; IV, inverse variance; CI, confidence interval. Studies are listed by
ages of patients receiving drug-eluting stents (DES) on log hazard ratio for late
coronary artery bypass grafting (OPCAB) on log hazard ratio for late mortality.
1352 The Journal of Thoracic and Cardiovascular Surpublication bias (P ¼ .88062). Metaregression analyses
revealed that the percentage of patients receiving DES was
statistically nonsignificantly associated with improved
PCS treatment estimates (P¼ .05908; Figure 1, B), whereas
that of those undergoing off-pump CABG was statistically
significantly associated with impaired CABG treatment esti-
mates (P ¼ .02157; Figure 1, C).
DISCUSSION
The results of our analysis of real-world clinical practice
(observational studies) suggest that PCS may increase latenary stenting (PCS) versus coronary artery bypass grafting (CABG). SE,
first author; publication data are given in Table 1. B, Regression of percent-
mortality. C, Regression of percentages of patients undergoing off-pump
gery c May 2010
Brief Research Report(2- to 4-year) mortality by 35% relative to CABG in patients
with ULMCA stenosis. The previous meta-analysis by Naik
and associates,1 combining unadjusted ORs from 10 studies,
had shown no difference between PCS and CABG at 1 year
(OR, 1.00; 95% CI, 0.70–1.41), 2 years (OR, 1.27; 95% CI,
0.83–1.94), and 3 years (OR, 1.11; 95% CI, 0.66–1.86). We
abstracted HRs, however, the most appropriate intervention
effect for summarizing time-to-event data, adjusted for po-
tential confounding from each individual observational
study, and combined them in our meta-analysis. Further-
more, metaregression analyses indicated that off-pump
CABG may serve as a potential covariate associated with
impaired CABG treatment effects.
Results of 2 randomized trials excluded from our analysis
(Table 2) were controversial. In the small (105 patients) trial
by Buszman and colleagues,3 there was a trend toward better
late (28  9.9 months) survival after PCS (3 vs 7 deaths in
PCS vs CABG group, risk ratio, 0.44; 95% CI, 0.12–1.60).
A post hoc analysis of the large (1800 patients) SYNTAX
(Synergy between Percutaneous Coronary InterventionThe Journal of Thoracic and Carwith Taxus and Cardiac Surgery) trial by Serruys and
coworkers4 showed 1-year rates of major adverse cardiac
or cerebrovascular events among patients with ULMCA
stenosis to be similar in the PCS and CABG groups
(15.8% and 13.7%, respectively, P ¼ .44). Regrettably,
the SYNTAX trial did not provide mortality data exclu-
sively for patients with ULMCA stenosis. Late results of
large, randomized trials are needed to confirm our findings.References
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